{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-082809","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.294038+00:00","generated_at":"2026-05-31T01:09:25.749964+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Citius extends employment agreement with EVP Holubiak and insider warrants to 2025","bullets":["Myron Holubiak's employment term extended by one year to Oct 31, 2025; all other terms unchanged.","Investor warrants for 2,793,297 shares at $0.77 held by CEO Mazur and EVP Holubiak extended to Sept 27, 2025.","Underwriter warrants for 194,358 shares at $1.11875 extended to same date, held by Wainwright representatives.","Full exercise of all extended warrants would yield ~$2.4M in cash proceeds to the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-082809","json":"https://secwatch.observer/filing/0001213900-24-082809.json","markdown":"https://secwatch.observer/filing/0001213900-24-082809.md","text":"https://secwatch.observer/filing/0001213900-24-082809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/0001213900-24-082809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/ea0215927-8k_citiuspharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:09:25.749964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}